Stock Under $10 with 50-100% upside potential - 14 Days FREE!

Walgreens Presents Growth Strategy At 2013 Annual Shareholders Meeting

Stock quotes in this article: WAG 

Reviewing a challenging but strategically important year for Walgreens (NYSE: WAG) (Nasdaq: WAG), Chairman James A. Skinner, President and Chief Executive Officer Gregory D. Wasson and Executive Vice President, Chief Financial Officer and President, International Wade D. Miquelon today outlined how the company is positioned for growth in fiscal year 2013 at Walgreens Annual Shareholders Meeting. Addressing more than 2,000 shareholders in Chicago, company leadership discussed the substantial progress Walgreens is making toward its vision to be the first choice in health and daily living in America – and beyond.

Wasson said, “With a strong foundation and the right strategies, structure and talent in place, and with many of last year’s headwinds becoming this year’s tailwinds, Walgreens is well-positioned to ensure its market leadership, growth and profitability well into the future on behalf of its customers and shareholders.”

Having reached new, multi-year agreements with pharmacy benefit managers Express Scripts, Optum Health and others, Walgreens is focused on three areas of opportunity ahead:

  • Delivering a complete Well Experience by transforming the customer experience across all of the company’s touch points, channels and formats
  • Transforming the role community pharmacy plays in health care by offering unparalleled access to innovative, high quality and affordable health and wellness services
  • Creating an unprecedented and efficient global platform through its strategic partnership with Alliance Boots GmbH

“We are taking a multi-pronged approach to delivering the Well Experience,” Wasson said. “We are combining leading-edge design with enhanced products and services, increased engagement with team members and customers, and an omni-channel approach that blends our brick-and-mortar stores with e-commerce and mobile commerce. We are deliberately blurring many retail channels to fit how consumers shop today.”

To that end, Walgreens has continued to expand its product offerings, including:

  • Expanded grocery items and fresh food in stores for on-the-go consumers with quick, convenient pickup, and a growing selection of healthy food choices that are important to underserved food desert communities.
  • Substantial investment continues in private brands, including Walgreens, Delish, Nice! and many more that have led to a 2 percentage points increase in private brand penetration year-over-year to 22 percent.
  • Enhanced beauty departments that now include an array of niche and prestige brands not found in traditional drugstores, including the introduction of Boots No7.
  • And mobile device capabilities that have expanded in the past year to include prescription refills and transfers by scanning the pill bottle; QuickPrints, an application that enables users to print photos directly from their devices to any Walgreens store; and in-store maps that allow customers to use a digital shopping list to map and locate items in a store.

Walgreens efforts to transform the role community pharmacy plays in health care begins with its pharmacists, who are seen more and more by patients as health care partners. Wasson said, “Walgreens pharmacists have administered more than 5 million flu shots in each of the past four years and today we are the largest retail provider of immunizations and vaccinations in the country, which validates that the public appreciates, wants and values what community pharmacy can do to support their health.”

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 15,303.10 8.60 0.06%
NASDAQ 3,459.14 -0.28 -0.01%
S&P 500 1,649.60 -0.91 -0.06%
US 10 Yr 2.011% -0.012

Brokerage Partners

Advertising Partners
Special Features

Free Newsletters from TheStreet

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy. Manage Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs